CIK 0001904286 · <br>Emerging growth company
MIRA PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MIRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- FL
- Entity type
- operating
- EIN
- 853354547
- Phone
- 813-369-5150
- Business address
- 1200 BRICKELL AVENUE, SUITE 1950 #1183, MIAMI, FL, 33131
- Former names
- Mira1a Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | Shekhat Denil Nanji Director | Grant or award · Nonqualified Stock Option (right to buy) | +50,000 | 41,666 | ||
| 2024-05-28 | Aminov Erez Chief Executive Officer | Grant or award · Incentive Stock Options (right to buy) | +379,000 | 629,000 | ||
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +2,000 | $1.00 | $2K | 375,500 |
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +1,000 | $1.03 | $1K | 376,500 |
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +500 | $1.02 | $510 | 377,000 |
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +2,000 | $0.84 | $2K | 379,000 |
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +1,000 | $0.85 | $850 | 380,000 |
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +600 | $0.87 | $522 | 380,600 |
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +800 | $1.01 | $808 | 381,400 |
| 2024-05-21 | Aminov Erez Chief Executive Officer | Purchase | +800 | $0.97 | $776 | 382,200 |
| 2024-03-26 | Yanez Michelle Chief Financial Officer | Grant or award · Incentive Stock Option (right to buy) | +150,000 | 57,799 | ||
| 2024-03-26 | Aminov Erez Chief Executive Officer | Grant or award · Incentive Stock Option (right to buy) | +300,000 | 250,000 | ||
| 2024-03-25 | Shekhat Denil Nanji Director | Grant or award · Nonqualified Stock Option (right to buy) | +50,000 | 25,000 | ||
| 2024-03-25 | Jerman Michael Allen Director | Grant or award · Nonqualified Stock Option (right to buy) | +50,000 | 25,000 | ||
| 2024-03-25 | Del Giudice Matthew Paul Director | Grant or award · Nonqualified Stock Option (right to buy) | +50,000 | 25,000 | ||
| 2024-03-25 | MacPherson Edward Clouston Director | Grant or award · Nonqualified Stock Option (right to buy) | +50,000 | 25,000 | ||
| 2023-12-11 | McNulty Brian Patrick 10% owner | Sale | −23,003 | $1.55 | $36K | 2,740,270 |
| 2023-12-11 | McNulty Brian Patrick 10% owner | Sale | −23,002 | $1.55 | $36K | 660,000 |
| 2023-12-08 | McNulty Brian Patrick 10% owner | Sale | −9,526 | $1.61 | $15K | 2,763,273 |
| 2023-12-08 | McNulty Brian Patrick 10% owner | Sale | −9,527 | $1.61 | $15K | 683,002 |
Page 2 of 4 · 65 trades